Product image of Gluconat De Calciu B.Braun Melsungen (Calcium Gluconate) supplied by GNH India

Gluconat De Calciu B.Braun Melsungen

Active Ingredient:
Calcium Gluconate
Origin:
EU

Gluconat De Calciu B.Braun Melsungen (Calcium Gluconate)

Gluconat De Calciu B.Braun Melsungen is an injectable calcium gluconate solution marketed in the EU. The product contains calcium gluconate as the active ingredient and is supplied as a sterile injection solution for intramuscular or intravenous administration, prescribed for correction of calcium deficits and related electrolyte disturbances.

Manufacturer / TM Owner

B.Braun Melsungen Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Gluconat De Calciu B.Braun Melsungen is indicated for several clinical situations where calcium supplementation is required.

  • Treatment of hypocalcemia caused by surgery, trauma, or endocrine disorders.
  • Management of calcium deficiency in patients with malabsorption or dietary insufficiency.
  • Cardiac membrane stabilization in hyperkalemia emergencies.
  • Peri‑operative calcium supplementation to support neuromuscular function.
  • Adjunct therapy in certain cases of osteomalacia or rickets under medical supervision.

Side Effects

Side effects of calcium gluconate injection can range from mild to severe, depending on patient factors and administration technique.

Common

  • Local pain, erythema, or swelling at the injection site.
  • Nausea or mild vomiting.
  • Transient flushing or warmth sensation.
  • Mild hypercalcemia manifested as constipation or mild fatigue.

Serious

  • Severe hypercalcemia leading to cardiac arrhythmias.
  • Hypotension or bradycardia during rapid IV infusion.
  • Tissue necrosis or ulceration from extravasation.
  • Anaphylactic or severe allergic reactions.
  • Cardiac arrest in extreme electrolyte imbalance.

Precautions & Warnings

Before administering Gluconat De Calciu B.Braun Melsungen, several safety considerations should be observed.

  • Verify serum calcium levels and correct any underlying electrolyte imbalance.
  • Monitor cardiac rhythm and blood pressure during rapid IV infusion.
  • Avoid administration to patients with known hypercalcemia or severe renal impairment.
  • Use caution in pregnant or breastfeeding women; safety data are limited.
  • Ensure proper IV/IM technique to prevent extravasation and tissue injury.
  • Adjust dose in patients receiving other calcium‑containing medications.

Avoid Interactions

Calcium gluconate may interact with various drugs, influencing their efficacy or safety.

Avoid

  • Simultaneous administration of calcium‑containing antacids or supplements that may cause hypercalcemia.
  • Concurrent use of bisphosphonates, which can bind calcium and reduce absorption.
  • High‑dose loop diuretics that increase calcium excretion.

Use with caution

  • Digoxin or quinidine, as calcium may affect cardiac conduction.
  • ACE inhibitors or thiazide diuretics, which can alter calcium balance.
  • Other electrolyte solutions (magnesium, potassium) that may require monitoring.
  • Blood thinners, as calcium can influence clotting factors.

Frequently Asked Questions

The product contains calcium gluconate as its sole active pharmaceutical ingredient.

It is commonly prescribed for hypocalcemia, calcium deficiency, and as a cardiac membrane stabilizer in hyperkalemia emergencies.

Yes, the formulation is approved for both intravenous (IV) and intramuscular (IM) routes of administration.

Continuous cardiac rhythm monitoring and blood pressure checks are recommended to detect arrhythmias or hypotension.

Safety data are limited; it should be used only if the potential benefit justifies the potential risk to the fetus.

Patients may experience mild pain, redness, swelling, or a warm sensation at the site of injection.

Proper IV catheter placement, slow infusion rates, and immediate cessation of infusion if resistance is felt can help prevent extravasation.

Patients with severe renal impairment require careful dosing and close monitoring of serum calcium levels.

Calcium‑containing antacids, bisphosphonates, and high‑dose loop diuretics should be avoided to reduce the risk of hypercalcemia.

Yes, calcium can affect cardiac conduction, so digoxin and similar agents should be used with caution.

The ATC classification for calcium gluconate is A12AA04.

No, it is a prescription‑only medication and is not available without a healthcare provider’s order.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.